What is Pharmaceutical Robots Market?
The pharmaceutical robots are used in the pharmaceutical company to perform various jobs that are done by humans and to perform tasks at rates beyond human capabilities. The use of robots in the pharmaceutical industry has many advantages. Robots can perform tasks three to four times faster than humans and can perform work 24 hours a day. Thus pharmaceutical companies can produce large quantities of products in a short period of time. Higher demand for increased production and a shortage of skilled labors will drive the pharmaceutical robot market. Increased spread of COVID-19 disease results in higher demand for pharmaceutical products such as face masks, antibiotics, life-saving drugs and instruments, sanitizers and other related products. On 3rd April 2020, The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of hydroxychloroquine sulfate supplied from the Strategic National Stockpile to treat adults and adolescents who weigh 50 kg or more and are hospitalized with COVID-19. Around 10% of infected people need ventilators worldwide. There is a shortage of ventilators as well as drugs such as Hydroxychloroquine worldwide. This creating pressure on pharmaceutical companies to increase their production. These companies are facing issues to increase their production such as shortage of skilled labors. Pharmaceutical robots can overcome this issue by reducing time and increasing production. This results in future demand for pharmaceutical robots in the market.
The market study is being classified by Type (Traditional Robots {Articulated, SCARA, Delta Parallel and Cartesian} and Collaborative Robots), by Application (Picking and Packaging, Inspection of Drugs and Laboratory Applications) and major geographies with country level break-up.
Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Universal Robots (Denmark), Yaskawa Electric Corporation (Japan) and Shibuya Corporation (Japan) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Marchesini Group S.p.A. (Italy), Stäubli International AG (Switzerland), Adept Technology Inc (United States) and Omron Adept Technologies (United States).
The pharmaceutical companies are focusing on automation in the production process. They are increasing their production to meet the market demand for these products. They are replacing the labors with the robots to gain a competitive advantage. Research Analyst at AMA predicts that Japan Players will contribute to the maximum growth of Global Pharmaceutical Robots market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Pharmaceutical Robots market by Type, Application and Region.
On the basis of geography, the market of Pharmaceutical Robots has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Increasing Demand for Pharmaceutical Products due to COVID-19 Spread
- Various Benefits of Robots like Lower Operating Cost
- Reduction in the Human Labors
Market Trend
- Introduction of Technological Advanced Robots
- Increased Automation in the Industry
Restraints
- Limitations of the Pharmaceutical Robots
Opportunities
- Increasing Use of Robots in the Pharmaceutical Industry
- Growing Pharmaceutical Industry
- Rising Focus of the Pharmaceutical Companies to Increase Production
Challenges
- High Investment Cost for Installment
Market Leaders and some development strategies
In September 2018, ABB announced it has completed its acquisition of intrion, a privately owned company with approximately 120 employees and over a decade of experience in logistics automation solutions and services for the logistics, food and beverage and pharmaceutical industries.
On 17th January 2019, KUKA launched new generation KR QUANTEC series robot with a payload capacity between 120 to 300 kg. The robots are designed to use in every market segment such as automotive industry, foundry sector and pharmaceutical industry.
Key Target Audience
Pharmaceutical Robot Manufacturers, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End-user